QT
ABEO icon

Quantbot Technologies’s Abeona Therapeutics ABEO Stock Holding History

Quantbot Technologies’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Buy
+25,349
New +$139K 0.01% 1346
2021
Q3 		– Sell
-128
Closed -$4K – 1464
2021
Q2 		$4K Buy
+128
New +$5.22K ﹤0.01% 1373
2018
Q4 		– Sell
-95
Closed -$30K – 987
2018
Q3 		$30K Buy
+95
New +$33.7K ﹤0.01% 1104

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Quantbot Technologies's ABEO Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Abeona Therapeutics (ABEO) in Q2 2026: 25,349 shares worth $157K. The stake represents 0.01% of the portfolio and ranks #1346 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in ABEO as recently as Q2 2021.

Quantbot Technologies first reported a position in ABEO in Q3 2018 and has held it in 3 quarters since. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Quantbot Technologies held 25,349 shares of Abeona Therapeutics worth $157K as of Q2 2026.
  • Abeona Therapeutics was a new Quantbot Technologies position in Q2 2026.
  • Abeona Therapeutics made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1346 holding.
  • Quantbot Technologies first reported a position in Abeona Therapeutics in Q3 2018 and has held it in 3 quarters since.
  • 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.